CSIMarket
 
G1 Therapeutics Inc   (NASDAQ: GTHX)
 

GTHX's Market share relative to its competitors, as of Q2 2024

As of Q2 2024 (Revenue in Millions of $)

Date modified: 2026-09-01T06:12:10+00:00





COMPANY NAME REVENUES
12 Months Ending
Q2 2024
MARKET SHARE
12 Months
Q2 2024
MARKET SHARE
MRQ
Q2 2024
MARKET SHARE
A Quarter Before
Q1 2024
G1 Therapeutics Inc 58.20 0.85% 0.68 % 0.83 %
Madrigal Pharmaceuticals Inc 1,132.49 16.62% 14.91% 17.80%
Supernus Pharmaceuticals inc 776.83 11.40% 8.96% 11.87%
Tg Therapeutics Inc 700.35 10.28% 9.84% 11.72%
Blueprint Medicines Corporation 562.12 8.25% 6.11% 8.37%
Hutchmed china Limited 548.51 8.05% 8.05% 0.00%
71 more competitors available

Sign in to see all competitors for G1 Therapeutics Inc .




GTHX's Market share relative to its competitors, as of Q2 2024 within the Major Pharmaceutical Preparations Industry
As of Q2 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2024
MARKET SHARE
12 Months Ending
Q1 2024
MARKET SHARE
MRQ
Q2 2024
MARKET SHARE

Q1 2024
G1 Therapeutics Inc 0.90% 1.35% 0.71 % 0.86 %
Madrigal Pharmaceuticals Inc 17.42% 15.44% 15.55% 18.60%
Supernus Pharmaceuticals inc 11.95% 11.58% 9.35% 12.41%
Tg Therapeutics Inc 10.77% 9.93% 10.26% 12.24%
Blueprint Medicines Corporation 8.65% 8.20% 6.38% 8.75%
Hutchmed china Limited 8.44% 10.15% 8.44% 10.15%
68 more companies available

Sign in to see all industry competitors for G1 Therapeutics Inc .




GTHX's Market share relative to its competitors, as of Q2 2024 within the Healthcare Sector
As of Q2 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q2 2024
MARKET SHARE
12 Months Ending
Q1 2024
MARKET SHARE
MRQ
Q2 2024
MARKET SHARE

Q1 2024
G1 Therapeutics Inc 0.86% 1.30% 0.68 % 0.83 %
Madrigal Pharmaceuticals Inc 16.68% 14.81% 14.92% 17.81%
Supernus Pharmaceuticals inc 11.44% 11.11% 8.97% 11.88%
Tg Therapeutics Inc 10.32% 9.52% 9.84% 11.72%
Blueprint Medicines Corporation 8.28% 7.86% 6.12% 8.37%
Hutchmed china Limited 8.08% 9.74% 8.08% 9.74%
70 more companies available

Sign in to see all sector competitors for G1 Therapeutics Inc .




Note: Market share is calculated based on total revenue. To get a more accurate picture of G1 Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit G1 Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.